Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Rosuvastatin Gel for Intrabony Defects in Chronic Periodontitis
NCT03204058Phase 3Completed
- Sponsor
- Government Dental College and Research Institute
- Start
- Feb 2016
- Primary completion
- Feb 2017
- Modality
- Hydrogel Systems, Small Molecules
01
Overview
Phase 3, randomised trial of metformin 1% gel and rosuvastatin 1.2% in situ gel in chronic periodontitis (3 arms), sponsored by Government Dental College and Research Institute. Primary endpoint: Change in Bone defect fill at 12 months. Started Feb 2016; status: completed.
02
Drugs
metformin 1% gelrosuvastatin 1.2% in situ gel
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT03204058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03204058.